Stablix Therapeutics

Updated: September 02, 2025
CEO - Clare Ozawa
CEO - Clare Ozawa
Country: USA | Funding: $63M (+)

Website: https://www.stablix.com/

Stablix Therapeutics, a biotechnology company pioneering the Targeted Protein Stabilization technologies that is used to cure cystic fibrosis and cancer

Competitors